Kavita Singh is a postdoctoral researcher at the Health Economics and Health Financing Unit of the Heidelberg Institute of Global Health, Heidelberg University, Germany. She has a secondary appointment as Senior Research Scientist, Public Health Foundation of India and an Adjunct Faculty at the Hubert Department of Global Health, Emory University, USA. Kavita is an epidemiologist by training and has more than a decade of research experience in global cardiovascular health epidemiology, clinical trials, implementation science, health systems and policy research. Kavita work across the spectrum of cardiovascular disease prevention in research on implementation and evaluation of quality improvement strategies, the interaction between COVID-19 and cardiovascular diseases, and health, psychosocial and economic impacts of COVID-19 on chronic conditions. In 2019, Kavita is the first Indian to receive the NIH Emerging Global Leader Award (K43 grant, 2019-2024), to conduct a study that aims to develop and test the feasibility/effectiveness of a collaborative quality improvement strategy for the secondary prevention of cardiovascular diseases in India.
Scientific background
2016 PhD, All India Institute of Medical Sciences, New Delhi, India
2013 MSc. (Short course) Economic Evaluation, London School of Hygiene and Tropical Medicine, United Kingdom (UK)
2008 MSc. (Clinical Research), Cranfield University, UK
2006 BSc. (Honors) Microbiology, University of Delhi, India
Selected Publications
Singh K, Xin Y, Xiao Y, Quan J, Kim D, Nguyen TP, Kondal D, Yan X, Li G, Ng CS, Kang H, Minh Nam H, Mohan S, Yan LL, Shi C, Chen J, Thi Hong Hanh H, Mohan V, Kong S, Eggleston K; Research Group on “COVID-19 and Chronic disease care in Asia”. Impact of the COVID-19 Pandemic on Chronic Disease Care in India, China, Hong Kong, Korea, and Vietnam. Asia Pac J Public Health. 2022 May;34(4):392-400. doi: 10.1177/10105395211073052.
Singh K, Bawa VS, Venkateshmurthy NS, Gandral M, Sharma S, Lodhi S, Wafford QE, Patel SA, Tandon N, Narayan KMV, Prabhakaran D, Huffman MD. Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients With Cardiovascular Disease. JAMA Netw Open. 2021 Jun 1;4(6):e2113375. doi: 10.1001/jamanetworkopen.2021.13375. PMID: 34125220; PMCID: PMC8204210.
Singh K, Kondal D, Mohan S, Jaganathan S, Deepa M, Venkateshmurthy NS, Jarhyan P, Anjana RM, Narayan KMV, Mohan V, Tandon N, Ali MK, Prabhakaran D, Eggleston K. Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods study. BMC Public Health. 2021 Apr 8;21(1):685. doi: 10.1186/s12889-021-10708-w. PMID: 33832478; PMCID: PMC8027966.
Singh K, Kaushik A, Johnson L, Jaganathan S, Jarhyan P, Deepa M, Kong S, Venkateshmurthy NS, Kondal D, Mohan S, Anjana RM, Ali MK, Tandon N, Narayan KMV, Mohan V, Eggleston K, Prabhakaran D. Patient experiences and perceptions of chronic disease care during the COVID-19 pandemic in India: a qualitative study. BMJ Open. 2021 Jun 18;11(6): e048926.
Singh K, Thanassoulis G, Dufresne L, Nguyen A, Gupta R, Narayan KV, Tandon N, Sniderman A, Prabhakaran D. A Comparison of Lipids and apoB in Asian Indians and Americans. Glob Heart. 2021 Jan 20;16(1):7.
